Companies

Alumni
3T Biosciences is solving major bottleneck in the field of immunotherapy - identifying
Alumni
QuickFire
Challenge Winner
At Ab Initio, we are using a proprietary directed evolution engineering technology to
Abilita Bio’s mission is to discover and develop transformative therapeutics by enabling
Alumni
Achelois’ mission is to develop effective and nontoxic therapeutics to inhibit tumors, and
Actavalon is developing small molecule therapeutics capable of restoring p53 tumor
Alumni
Convoy’s technology platform focuses on solving major unmet needs in aesthetics and
Alumni
Adicet is developing a novell cell therapy platform.
Discovery and synthesis of a large portfolio of small molecules that prevent the ability
Alumni
Targeting sensitized nerves to treat chronic & debilitating neurogenic disorders
Alumni
Agenovir is developing a novel class of nuclease-based anti-viral therapeutics for
Alume Biosciences is developing a fluorescent nerve labeling agent for precision surgery.
Alumni
Amplyx Pharmaceuticals Inc is a preclinical stage company that re-engineers small molecule
Alumni
Our mission is to be the leader in detecting/monitoring Alzheimer’s disease. We are